Literature DB >> 27846173

Current Controversies in Transanal Surgery for Rectal Cancer.

Jose M Ramirez1, Manuela Elia, Elena Cordoba, Jose A Gracia, Vicente Aguilella.   

Abstract

Local surgery for rectal tumors has been traditionally limited due to technical issues for lower risk lesions. In the 1980s, Buess described the transanal endoscopic microsurgery (TEM) technique that enabled excision of lesions that were larger and in a higher location. TEM in a short time became the gold standard for the excision of large adenomas and early rectal carcinomas. Since the advent of TEM, and due to advances in minimal invasive technology, new devices and procedures have come to the surgical armamentarium, in many cases with only very slight differences between them. However, local surgery for rectal cancer still remains a challenge. An overview of the current status of minimal transanal invasive techniques is presented here and sheds some light on the controversies that the local management of rectal cancer still raises.

Entities:  

Mesh:

Year:  2016        PMID: 27846173     DOI: 10.1097/SLE.0000000000000357

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  3 in total

1.  First clinical experience with single-port robotic transanal minimally invasive surgery (SP rTAMIS) for benign rectal neoplasms.

Authors:  J H Marks; E Kunkel; J F Salem; C Martin; B Anderson; S Agarwal
Journal:  Tech Coloproctol       Date:  2020-10-17       Impact factor: 3.781

2.  Morbidity after transanal endoscopic microsurgery: risk factors for postoperative complications and the design of a 1-day surgery program.

Authors:  Xavier Serra-Aracil; Maritxell Labró-Ciurans; Pere Rebasa; Laura Mora-López; Anna Pallisera-Lloveras; Sheila Serra-Pla; Raquel Gracia-Roman; Salvador Navarro-Soto
Journal:  Surg Endosc       Date:  2018-09-10       Impact factor: 4.584

3.  Local full-thickness excision for sessile adenoma and cT1-2 rectal cancer: long-term oncological outcome.

Authors:  Maria A Gascon; Vicente Aguilella; Tomas Martinez; Luigi Antinolfi; Javier Valencia; Jose M Ramírez
Journal:  Langenbecks Arch Surg       Date:  2022-06-22       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.